US Stock MarketDetailed Quotes

Candel Therapeutics (CADL)

Watchlist
  • 4.830
  • +0.030+0.63%
Close Apr 10 16:00 ET
  • 4.840
  • +0.010+0.21%
Post 19:35 ET
353.78MMarket Cap-6.71P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Candel Therapeutics (CADL) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
44.37%48.18M
92.40%15.66M
50.82%13.21M
30.40%11.18M
2.89%8.13M
-13.08%33.37M
-21.37%8.14M
-1.04%8.76M
-10.41%8.57M
-17.87%7.9M
Selling and administrative expenses
26.41%17.77M
42.12%4.72M
42.05%4.75M
16.54%4.19M
8.26%4.11M
1.24%14.06M
8.63%3.32M
10.78%3.34M
-1.45%3.59M
-8.74%3.8M
-General and administrative expense
26.41%17.77M
42.12%4.72M
42.05%4.75M
16.54%4.19M
8.26%4.11M
1.24%14.06M
8.63%3.32M
10.78%3.34M
-1.45%3.59M
-8.74%3.8M
Research and development costs
57.90%30.5M
128.94%11.03M
56.22%8.46M
40.41%6.99M
-2.10%4.02M
-21.19%19.31M
-33.63%4.82M
-7.34%5.42M
-16.09%4.98M
-25.00%4.1M
Other operating expenses
---89K
----
----
----
----
----
----
----
----
----
Operating profit
-44.37%-48.18M
-92.40%-15.66M
-50.82%-13.21M
-30.40%-11.18M
-2.89%-8.13M
13.08%-33.37M
21.37%-8.14M
1.04%-8.76M
10.41%-8.57M
17.87%-7.9M
Net non-operating interest income expense
278.88%1.8M
-214.00%-314K
415.54%792K
311.01%690K
292.64%628K
-95.33%-1M
61.24%-100K
-50.30%-251K
-71.20%-327K
-419.61%-326K
Non-operating interest income
260.50%3.92M
280.00%1.1M
303.81%953K
285.83%926K
191.88%934K
-47.81%1.09M
-30.12%290K
-52.99%236K
-47.02%240K
-54.99%320K
Non-operating interest expense
1.39%2.12M
263.08%1.42M
-66.94%161K
-58.38%236K
-52.63%306K
-19.46%2.09M
-42.05%390K
-27.20%487K
-11.96%567K
6.08%646K
Other net income (expense)
139.41%8.2M
-131.81%-13.52M
169.96%1.15M
142.66%5.69M
212,485.71%14.88M
-2,253.42%-20.8M
-1,107.45%-5.83M
-381.93%-1.64M
-9,363.19%-13.34M
-99.03%7K
Gain on sale of security
139.41%8.2M
-131.81%-13.52M
169.96%1.15M
142.66%5.69M
212,485.71%14.88M
-2,253.42%-20.8M
-1,107.45%-5.83M
-381.93%-1.64M
-9,363.19%-13.34M
-99.03%7K
Income before tax
30.80%-38.18M
-109.59%-29.5M
-5.85%-11.27M
78.43%-4.8M
189.76%7.38M
-45.44%-55.18M
-26.84%-14.07M
-26.21%-10.65M
-131.30%-22.24M
6.53%-8.22M
Income tax
Net income
30.80%-38.18M
-109.59%-29.5M
-5.85%-11.27M
78.43%-4.8M
189.76%7.38M
-45.44%-55.18M
-26.84%-14.07M
-26.21%-10.65M
-131.30%-22.24M
6.53%-8.22M
Net income continuous Operations
30.80%-38.18M
-109.59%-29.5M
-5.85%-11.27M
78.43%-4.8M
189.76%7.38M
-45.44%-55.18M
-26.84%-14.07M
-26.21%-10.65M
-131.30%-22.24M
6.53%-8.22M
Minority interest income
Net income attributable to the parent company
30.80%-38.18M
-109.59%-29.5M
-5.85%-11.27M
78.43%-4.8M
189.76%7.38M
-45.44%-55.18M
-26.84%-14.07M
-26.21%-10.65M
-131.30%-22.24M
6.53%-8.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
30.80%-38.18M
-109.59%-29.5M
-5.85%-11.27M
78.43%-4.8M
189.76%7.38M
-45.44%-55.18M
-26.84%-14.07M
-26.21%-10.65M
-131.30%-22.24M
6.53%-8.22M
Basic earnings per share
58.62%-0.72
-35.00%-0.54
36.36%-0.21
87.84%-0.09
153.57%0.15
-32.82%-1.74
-5.26%-0.4
-13.79%-0.33
-124.24%-0.74
6.67%-0.28
Diluted earnings per share
58.62%-0.72
-35.00%-0.54
36.36%-0.21
87.84%-0.09
146.43%0.13
-32.82%-1.74
-5.26%-0.4
-13.79%-0.33
-124.24%-0.74
6.67%-0.28
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 44.37%48.18M92.40%15.66M50.82%13.21M30.40%11.18M2.89%8.13M-13.08%33.37M-21.37%8.14M-1.04%8.76M-10.41%8.57M-17.87%7.9M
Selling and administrative expenses 26.41%17.77M42.12%4.72M42.05%4.75M16.54%4.19M8.26%4.11M1.24%14.06M8.63%3.32M10.78%3.34M-1.45%3.59M-8.74%3.8M
-General and administrative expense 26.41%17.77M42.12%4.72M42.05%4.75M16.54%4.19M8.26%4.11M1.24%14.06M8.63%3.32M10.78%3.34M-1.45%3.59M-8.74%3.8M
Research and development costs 57.90%30.5M128.94%11.03M56.22%8.46M40.41%6.99M-2.10%4.02M-21.19%19.31M-33.63%4.82M-7.34%5.42M-16.09%4.98M-25.00%4.1M
Other operating expenses ---89K------------------------------------
Operating profit -44.37%-48.18M-92.40%-15.66M-50.82%-13.21M-30.40%-11.18M-2.89%-8.13M13.08%-33.37M21.37%-8.14M1.04%-8.76M10.41%-8.57M17.87%-7.9M
Net non-operating interest income expense 278.88%1.8M-214.00%-314K415.54%792K311.01%690K292.64%628K-95.33%-1M61.24%-100K-50.30%-251K-71.20%-327K-419.61%-326K
Non-operating interest income 260.50%3.92M280.00%1.1M303.81%953K285.83%926K191.88%934K-47.81%1.09M-30.12%290K-52.99%236K-47.02%240K-54.99%320K
Non-operating interest expense 1.39%2.12M263.08%1.42M-66.94%161K-58.38%236K-52.63%306K-19.46%2.09M-42.05%390K-27.20%487K-11.96%567K6.08%646K
Other net income (expense) 139.41%8.2M-131.81%-13.52M169.96%1.15M142.66%5.69M212,485.71%14.88M-2,253.42%-20.8M-1,107.45%-5.83M-381.93%-1.64M-9,363.19%-13.34M-99.03%7K
Gain on sale of security 139.41%8.2M-131.81%-13.52M169.96%1.15M142.66%5.69M212,485.71%14.88M-2,253.42%-20.8M-1,107.45%-5.83M-381.93%-1.64M-9,363.19%-13.34M-99.03%7K
Income before tax 30.80%-38.18M-109.59%-29.5M-5.85%-11.27M78.43%-4.8M189.76%7.38M-45.44%-55.18M-26.84%-14.07M-26.21%-10.65M-131.30%-22.24M6.53%-8.22M
Income tax
Net income 30.80%-38.18M-109.59%-29.5M-5.85%-11.27M78.43%-4.8M189.76%7.38M-45.44%-55.18M-26.84%-14.07M-26.21%-10.65M-131.30%-22.24M6.53%-8.22M
Net income continuous Operations 30.80%-38.18M-109.59%-29.5M-5.85%-11.27M78.43%-4.8M189.76%7.38M-45.44%-55.18M-26.84%-14.07M-26.21%-10.65M-131.30%-22.24M6.53%-8.22M
Minority interest income
Net income attributable to the parent company 30.80%-38.18M-109.59%-29.5M-5.85%-11.27M78.43%-4.8M189.76%7.38M-45.44%-55.18M-26.84%-14.07M-26.21%-10.65M-131.30%-22.24M6.53%-8.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 30.80%-38.18M-109.59%-29.5M-5.85%-11.27M78.43%-4.8M189.76%7.38M-45.44%-55.18M-26.84%-14.07M-26.21%-10.65M-131.30%-22.24M6.53%-8.22M
Basic earnings per share 58.62%-0.72-35.00%-0.5436.36%-0.2187.84%-0.09153.57%0.15-32.82%-1.74-5.26%-0.4-13.79%-0.33-124.24%-0.746.67%-0.28
Diluted earnings per share 58.62%-0.72-35.00%-0.5436.36%-0.2187.84%-0.09146.43%0.13-32.82%-1.74-5.26%-0.4-13.79%-0.33-124.24%-0.746.67%-0.28
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.02%
Sample Name
Sample Code
 +5.43%
Sample Name
Sample Code
 +2.46%
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+1.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+0.70%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.34%
Sample Name
Sample Code
 +11.49%
Sample Name
Sample Code
 +10.29%
4
Futu Holdings Ltd
FUTU
+10.23%
5
Hesai
HSAI
+9.84%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -